Australia markets closed

Teva Pharmaceutical Industries Limited (TEVA)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
17.28+0.18 (+1.05%)
At close: 04:00PM EDT
17.03 -0.25 (-1.45%)
After hours: 07:45PM EDT
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-478,000
-559,000
-2,446,000
417,000
-3,990,000
-
Depreciation & amortisation
1,121,000
1,153,000
1,308,000
1,330,000
1,557,000
-
Deferred income taxes
-400,000
-317,000
-1,064,000
-120,000
-696,000
-
Stock-based compensation
117,000
121,000
124,000
119,000
129,000
-
Change in working capital
-220,000
-72,000
1,355,000
-1,701,000
-2,188,000
-
Accounts receivable
-
12,000
334,000
-574,000
-293,000
-
Inventory
-
-147,000
-163,000
380,000
41,000
-
Accounts payable
-
1,588,000
2,012,000
764,000
-463,000
-
Other working capital
878,000
842,000
1,042,000
236,000
638,000
-
Other non-cash items
29,000
61,000
-91,000
26,000
180,000
-
Net cash provided by operating activities
1,389,000
1,368,000
1,590,000
798,000
1,216,000
-
Cash flows from investing activities
Investments in property, plant and equipment
-511,000
-526,000
-548,000
-562,000
-578,000
-
Acquisitions, net
-15,000
0
-7,000
0
-
-
Purchases of investments
-54,000
-46,000
-1,000
-47,000
-55,000
-
Sales/maturities of investments
-
0
4,000
172,000
12,000
-
Other investing activities
-
-5,000
-
1,000
12,000
56,000
Net cash used for investing activities
931,000
968,000
656,000
1,523,000
863,000
-
Cash flows from financing activities
Debt repayment
-1,700,000
-4,852,000
-1,369,000
-7,840,000
-2,430,000
-
Dividends paid
-
-
-
-
-
-52,000
Other financing activities
-358,000
-212,000
-118,000
-6,000
-5,000
-
Net cash used provided by (used for) financing activities
-1,358,000
-1,913,000
-1,487,000
-2,172,000
-1,885,000
-
Net change in cash
815,000
393,000
636,000
21,000
202,000
-
Cash at beginning of period
2,176,000
2,834,000
2,198,000
2,177,000
1,975,000
-
Cash at end of period
3,137,000
3,227,000
2,834,000
2,198,000
2,177,000
-
Free cash flow
Operating cash flow
1,389,000
1,368,000
1,590,000
798,000
1,216,000
-
Capital expenditure
-511,000
-526,000
-548,000
-562,000
-578,000
-
Free cash flow
878,000
842,000
1,042,000
236,000
638,000
-